OrbiMed Advisors LLC's Form 4 filing
Adicet Bio, Inc. (ACET) · filed Apr 9, 2026
- Accession no.
- 0000947871-26-000421
- Filed
- Apr 9, 2026, 5:38 PM ET
- Trade date
- Apr 7-8, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $674.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Israel GP Ltd.CIK 0001569590 | 10% Owner |
| OrbiMed Israel BioFund GP Limited PartnershipCIK 0001569821 | 10% Owner |
| OrbiMed Capital GP V LLCCIK 0001615374 | 10% Owner |
| OrbiMed Israel GP II, L.P.CIK 0001682090 | 10% Owner |
| OrbiMed Advisors Israel II LtdCIK 0001682093 | 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Common Stock | SSaleDisposed | −29,319 | $6.53 | −$191,453.07 | 34,923 | Indirect | |
| Apr 7, 2026 | Common Stock | SSaleDisposed | −2,400 | $6.38 | −$15,312 | 32,523 | Indirect | |
| Apr 8, 2026 | Common Stock | SSaleDisposed | −32,523 | $6.29 | −$204,569.67 | 0 | Indirect | |
| Apr 8, 2026 | Common Stock | SSaleDisposed | −40,416 | $6.52 | −$263,512.32 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.